Prof. MD. Nuriye Taşdelen Fışgın

Education

• 1988-1994 Uludağ University Faculty of Medicine

• 1998-2002 Ankara Numune Training and Research Hospital, Infectious Diseases and Clinical Microbiology

Experience

• 1995-1997 Social Security Hospital, Emergency Department

• 1998-2002 Infectious Diseases Clinic, Ankara Numune Training and Research Hospital

• 2002-2011 Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Assistant Professor

• 2004 College of Medicine Infectious Diseases Center, University of Cincinnati, USA, HIV/AIDS Clinic

• 2011-2015 Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Associate Professor

• 2015-2017 Haseki Training and Research Hospital, Infectious Diseases and Clinical Microbiology Clinic

• 2017-2019 Demiroğlu Bilim University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Professor

• 2019-Present İstinye University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Professor

Professional Memberships

• Turkish Society of Microbiology and Infectious Diseases (KLIMIK)

• Chair, KLIMIK Working Group on Sexually Transmitted Infections

• Chair, Education Programs Development Committee, Board of Education and Competence in Infectious Diseases and Clinical Microbiology

• Turkish Medical Association

Research

• Effect of Proinflammatory and Anti-inflammatory Cytokines on Mortality in Crimean-Congo Hemorrhagic Fever Patients, Ondokuz Mayıs University Scientific Research Commission, T-522, Assistant Researcher, 2007

• Determination of T-Helper 1 (Th1) and T-Helper 2 (Th2) Cytokine (IL-1a, IL-1b, IL-R, IL-Ra, IL-2, IL-4, IL-4ra, IL-6, IL-10, IL-12, IFN-γ, TGF-β, TNF-α) Gene Polymorphisms in Patients with Brucellosis and Meningitis, Ondokuz Mayıs University Scientific Research Commission, T-523, Assistant Researcher, 2007

• Effects of Reactive Oxygen and Nitrogen Intermediates Alone and in Combination with Various Antibiotics on Brucella Isolates, Ondokuz Mayıs University Scientific Research Commission, T-434, Assistant Researcher, 2006

• Comparison of Malondialdehyde, Superoxide Dismutase, Glutathione Peroxidase, Myeloperoxidase, and TNF-α Levels in Patients with Chronic Hepatitis B and C and Their Effect on Disease Progression, Ondokuz Mayıs University Scientific Research Commission, T-435, Project Manager, 2005

• Comparison of Procalcitonin, Neopterin, and Nitric Oxide Levels in Patients with Sepsis, Ondokuz Mayıs University Scientific Research Commission, T-383, Project Manager, 2004

International Peer-Reviewed Journal Articles

• Tekin S, Keske S, Alan S, Batirel A, Karakoc C, Tasdelen-Fisgin N, Simsek-Yavuz S, Isler B, Aydin M, Kapmaz M, Yilmaz-Karadag F, Ergonul O. Predictors of Fatality in Influenza A Virus Subtype Infections Among Inpatients in the 2015-2016 Season. Int J Infect Dis. 2019 Apr;81:6-9.

• Sayan M, Sargin F, Inan D, Sevgi DY, Celikbas AK, Yasar K, Kaptan F, Kutlu S, Fisgin NT, Inci A, Ceran N, Karaoglan I, Cagatay A, Celen MK, Koruk ST, Ceylan B, Yildirmak T, Akalin H, Korten V, Willke A. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey. AIDS Res Hum Retroviruses. 2016 Jan;32(1):26-31.

• Dokuzoguz B, Korten V, Gökengin D, Fincanci M, Yildirmak T, Kes UN, Tasdelen Fisgin N, Inan D, Eraksoy H, Akalin H. Transmission Route and Reasons for HIV Testing Among Recently Diagnosed HIV Patients in HIV-TR Cohort, 2011-2012. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19595.

• Korten V, Gökengin D, Fincanci M, Yildirmak T, Kes NU, Fisgin NT, Inan D, Eraksoy H, Akalin H, Kaptan F. Outcomes of Initial Antiretroviral Treatment (ART) Among Recently Diagnosed HIV Patients in HIV-TR Cohort, 2011-2012. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19678.

• Sayan M, Sargýn F, Inan D, Sevgi DY, Celikbas AK, Yasar K, Kaptan F, Kutlu SS, Fisgin NT, Inci A, Ceran N, Karaoglan Y, Cagatay A, Celen MK, Koruk ST, Ceylan B, Yýldýrmak T, Akalýn H, Korten V, Willke A. Transmitted Antiretroviral Drug Resistance Mutations in Newly Diagnosed HIV-1 Positive Patients in Turkey. J Int AIDS Soc. 2014 Nov 2;17(3):158-159.

• Deveci A, Coban AY, Tanrıverdi Çaycı Y, Acicbe O, Tasdelen Fisgin N, Akgüneş A, Ozatlı D, Uzun M, Durupinar B. In Vitro Effect of Ankaferd Blood Stopper®, a Plant Extract Against Mycobacterium Tuberculosis Isolates. Mikrobiyol Bul. 2013 Jan;47(1):71-8.

• Tasdelen Fisgin N, Aydin BK, Sarikaya H, Tanyel E, Esen S, Sunbul M, Leblebicioglu H. Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis B. Clin Lab. 2012;58(3-4):273-80.

• Tasdelen Fisgin N, Aliyazicioglu Y, Tanyel E, Coban AY, Ulger F, Zivalioglu M, Esen S, Leblebicioglu H. The Value of Neopterin and Procalcitonin in Patients With Sepsis. South Med J. 2010 Mar;103(3):216-9.

• Tanyel E, Coban AY, Fisgin NT, Tulek N. The Effect of Tigecycline and Ertapenem Against Clinical Isolates of Brucella Melitensis Detected by E-Test on Different Media. Indian J Med Microbiol. 2010 Oct-Dec;28(4):370-1.

• Tasdelen Fisgin N, Doganci L, Tanyel E, Tulek N. Initial High Rate of Misdiagnosis in Crimean Congo Haemorrhagic Fever Patients in an Endemic Region of Turkey. Epidemiol Infect. 2009 Jul 7:1-6.

• Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The Role of Ribavirin in the Therapy of Crimean Congo Hemorrhagic Fever: Early Use Is Promising. Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):929-33.

• Tasdelen Fisgin N, Y Tanriverdi Cayci, Coban AY, D Ozatli, Tanyel E, Durupinar B, Tulek N. Antimicrobial Activity of Plant Extract Ankaferd Blood Stopper. Fitoterapia. 2009;80:48-50.

• Tanyel E, AY Coban, Tasdelen Fisgin N, Tülek N, Durupinar B. In Vitro Effect of Reactive Nitrogen and Oxygen Intermediates Alone and in Combination With Some Antibiotics Against Brucella Melitensis Clinical Isolates. Mikrobiyol Bul. 2009;43:19-26.

• Aydin B, Tanyel E, Colak B, Fisgin NT, Tulek N. Infection Control Implementations at Forensic Medicine Practice: A National Survey in Turkey. Am J Forensic Med Pathol. 2009 Jun;30(2):167-70.

• Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk Factors for Fatality in Patients With Crimean-Congo Haemorrhagic Fever. Trop Doct. 2009 Jul;39(3):158-60.

• Sünbül M, Zivalioğlu M, Tasdelen Fisgin N. Community-Acquired Pseudomonas Stutzeri Meningitis in an Immunocompetent Patient. Mikrobiyol Bul. 2009;43:159-162.

• Tanyel E, Tasdelen Fisgin N, Esen S, Darka O, Bahcivan, Leblebicioglu H, Tulek N. An Unusual Case: Moraxella Catarrhalis Endocarditis in an Immunocompetent Patient. Mikrobiyol Bul. 2009 Oct;43(4):667-70.

• Doganci L, Ceyhan M, Tasdelen Fisgin N, Sarikayalar H, Tulek N. Crimean Congo Hemorrhagic Fever and Diffuse Alveolar Haemorrhage. Trop Doct. 2008;38:252-254.

• Tasdelen Fisgin N, Fisgin T, Tanyel E, Doganci L, Tulek N, Guler N, Duru F. Crimean-Congo Hemorrhagic Fever: Five Patients With Hemophagocytic Syndrome. Am J Hematol. 2008;83:73-76.

• Tanyel E, Tasdelen Fisgin N, Yildiz L, Leblebicioglu H, Doganci L, Tulek N. Panniculitis as the Initial Manifestation of Brucellosis: A Case Report. Am J Dermatopathol. 2008;30:169-171.

• Tanyel E, Tasdelen Fisgin N, Sarikaya Genc H, Doganci L, Tulek N. Brucella Epididymo-Orchitis Relapsing Three Times Despite Treatment. Int J Infect Dis. 2008;12:215-217.

• Coban AY, Bilgin K, Tasdelen Fisgin N, Uzun M, Durupinar B. Effect of Meropenem Against Multidrug-Resistant Mycobacterium Tuberculosis. J Chemother. 2008;20:395-396.

• Tasdelen Fisgin N, Candir N, Sunbul M. Intracranial Aspergillosis in an Immunocompetent Patient. Mikrobiyol Bul. 2007;41:303-307.

• Tanyel E, Tasdelen Fisgin N, Sarikaya Genç H, Tülek N. A Case of Secondary Syphilis With Hepatitis. Mikrobiyol Bul. 2007;41:291-296.

• Coban AY, Darka O, Tasdelen Fisgin N, Tanyel E, Cetinkaya Sensoy E, Hepsert SA, Birinci A, Durupinar B. Short Communication: Use of Cefoxitin Disc Diffusion Method for the Detection of Methicillin Resistance in Staphylococcus Aureus Clinical Isolates. Mikrobiyol Bul. 2007;41:109-113.

• Coban AY, Tanyel E, Tasdelen Fisgin N, Darka O, Tulek N, Durupinar B. Mutant Prevention Concentrations of Tetracycline, Rifampicin and Ciprofloxacin for Brucella Melitensis. J Chemother. 2007;19:596-598.

• Doganci L, Tasdelen Fisgin N. Crimean Congo Hemorrhagic Fever as an Indication for Use of Ribavirin. Pak J Med Sci. 2007;23:657.

• Coban AY, Bilgin K, Uzun M, Tasdelen Fisgin N, Akgunes A, Cihan CC, Birinci A, Durupinar B. Susceptibilities of Mycobacterium Tuberculosis to Isoniazid and Rifampin on Blood Agar. J Clin Microbiol. 2005;43:1930-1931.

• Coban AY, Darka O, Tasdelen Fisgin N, Cihan CC, Bilgin K, Akgunes A, Guven T, Dokuzoguz B, Birinci A, Durupinar B. The Resazurin Microplate Method for Rapid Detection of Vancomycin Resistance in Enterococci. J Chemother. 2005;4:361-366.

• Doganci L, Tasdelen Fisgin N, Sarikaya Genc H, Tulek N. Fatal Tetanus: Misdiagnosed & Operated as Surgical Acute Abdomen. Case Rep Clin Pract Rev. 2007;8:169-171.

• Doganci L, Kaya T, Tanyel E, Tasdelen Fisgin N, Gundogdu H, Kaygusuz G, Kuzu I. Fever, Giant Hepatic Cyst, Pancytopenia and T-Cell Lymphoma. Case Rep Clin Pract Rev. 2007;8:203-206.

Presentations at International Scientific Meetings and Published in Conference Proceedings

• Nuriye Tasdelen-Fisgin. Combination Therapy in Gram-Negative Bacterial Infections. XIX Turkish International Congress of Clinical Microbiology and Infectious Diseases, 2018, Antalya (Conference/Oral Presentation).

• Aslıhan Demirel, Nur Efe İris, Esin Çevik, Safiye Koçulu, Arzu Baygül, Nuriye Fisgin. Investigation of Catheter-Related Bloodstream Infections Developing in Our Group Hospitals Between 2013-2017. XIX Turkish International Congress of Clinical Microbiology and Infectious Diseases, 2018, Antalya (Poster).

• V. Korten, M. Fincancı, A. Gündüz, T. Yıldırmak, D. Gökengiz, N. Tasdelen Fisgin, D. İnan, H. Akalın, HIV-TR Cohort Study Group. Immunovirologic Outcome of Initial Antiretroviral Treatment Among Recently Diagnosed HIV Patients in Turkey: Results of HIV-TR Cohort. 14th European AIDS Conference, October 16-19, 2013.

• V. Korten, D. İnan, T. Yıldırmak, Ç. Ataman Hatipoğlu, N. Uzun Kes, N. Tasdelen Fisgin, H. Akalın, A. İnan, M. Sayan, HIV-TR Cohort Study Group. Prevalence of Transmitted Drug Resistance (TDR) in Newly Diagnosed HIV-1 Infected Patients in Turkey. 14th European AIDS Conference, October 16-19, 2013.

• M. Fincancı, V. Korten, N. Uzun, T. Yıldırmak, D. Gökengiz, N. Tasdelen Fisgin, B. Dokuzoğuz, F. Kaptan, HIV-TR Cohort Study Group. Spectrum of Opportunistic Diseases in Newly Diagnosed Patients in a Multicenter Cohort of HIV-Infected Patients From Turkey. 14th European AIDS Conference, October 16-19, 2013.

• M. Sayan, A. Willke, N. T. Fisgin, İ. Karaoglan, F. Sargın, A. Inci, A. Gündüz, N. Ceran, A. Celikbas, T. Yildirmak. Antiretroviral Drug Resistance Mutations in Treatment-Naive Turkish Patients Infected With HIV-1. 14th European AIDS Conference, October 16-19, 2013.

• N. Tasdelen Fisgin, O. Ergonul, L. Doganci, N. Tulek. Early Ribavirin Use in Crimean Congo Hemorrhagic Fever: Significant Positive Impact on Prognosis. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) & 46th Annual Meeting of the Infectious Diseases Society of America (IDSA), Washington, USA, Abstract Book 714, 2008.

• N. Tasdelen Fisgin, L. Doganci, E. Tanyel, N. Tulek. Initial High Rate of Misdiagnosis in Crimean Congo Hemorrhagic Fever Patients in an Endemic Region in Turkey. 48th Annual ICAAC & 46th Annual IDSA Meeting, Washington, USA, Abstract Book 714, 2008.

• N. Tasdelen Fisgin, E. Tanyel, N. Tulek. Risk Factors Among Patients With Crimean-Congo Hemorrhagic Fever. 17th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID), Munich, International Journal of Antimicrobial Agents, Vol 29, Suppl II, 280, Germany, 2007.

• N. Tasdelen Fisgin, T. Fisgin, F. Ulger, S. Esen, E. Tanyel, M. Zivalioglu, H. Leblebicioglu. Protein Z, Other Natural Anticoagulants, and Procalcitonin Levels in Adult Patients With Sepsis. 17th ESCMID, Munich, International Journal of Antimicrobial Agents, Vol 29, Suppl II, 496, Germany, 2007.

• AY Coban, E. Tanyel, N. Tasdelen Fisgin, O. Darka, N. Tulek, B. Durupinar. Mutant Prevention Concentrations of Ciprofloxacin for Brucella Melitensis. 16th ESCMID, Nice, France, Abstract R1919, 2006.

• B. Aydin, E. Tanyel, B. Colak, N. Tasdelen Fisgin, N. Tulek. Infection Control Practice in Forensic Medicine. 16th ESCMID, Nice, France, Abstract R2108, 2006.

• C. Aygün, Ş. Küçüködük, A. Birinci, N. Tasdelen Fisgin. Lipid Complex or Liposomal Amphotericin B for Candida Albicans Sepsis in Extremely Low Birth Weight Infants. 1st Congress of Union of Mediterranean Neonatal Societies & XIIth National Congress of Neonatology, İstanbul, 2003, Abstract 210.

• A. Kocagül Çelikbaş, N. Tasdelen Fisgin, Ş. Eren, N. Baykam, Ö. Ergönül, B. Dokuzoğuz. Long-Term Follow-Up of Patients With Acute Hepatitis B. FEMS Symposium, Laboratory Monitoring of Viral Infections and Antiviral Resistance Detection, İstanbul, 2000, Abstract 35.

National Books or Book Chapters

• N. Tasdelen Fisgin, Ö. Altuntaş Aydın. “HIV and Tuberculosis Coinfection.” In HIV/AIDS Diagnosis, Monitoring, and Treatment Handbook, Eds. D. Gökengin, B. Kurtaran, V. Korten, F. Tabak, S. Ünal, Chapter VI, pp. 84–92. Turkish HIV/AIDS Platform Publication, Istanbul, 2018.

• N. Tülek, N. Tasdelen Fisgin. “Acute Bacterial Meningitis.” In Infectious Diseases and Microbiology, Eds. A. Wilke Topçu, G. Söyletir, M. Doğanay, Vol. 1, pp. 1275–1303. Nobel Medical Publishing, Istanbul, 2017.

• T. Yıldırmak, N. Tasdelen-Fisgin. HIV Information Book. HIVCG, Klimik Publication, Istanbul, 2016.

• N. Tülek, N. Tasdelen Fisgin. “Acute Bacterial Meningitis.” In Infectious Diseases and Microbiology, Eds. A. Wilke Topçu, G. Söyletir, M. Doğanay, Vol. 1, pp. 1390–1422. Nobel Medical Publishing, Istanbul, 2008.

National Peer-Reviewed Journal Articles

• N. Tasdelen Fisgin, F. Tunç Fisgin. “Infection and Hemostasis.” Turkiye Klinikleri J Hematol-Special Topics, 2015; 8(2): 6–12.

• N. Tasdelen Fisgin. “Crimean-Congo Hemorrhagic Fever: Pathogenesis and Clinical Findings.” Turkiye Klinikleri J Inf Dis-Special Topics, 2014; 7(2): 14–18.

• N.T. Fisgin, E. Tanyel, B. Çiçek, N. Çandır, N. Tulek. “Evaluation of Patients Developing Candidemia.” İnfeksiyon Dergisi, 2009; 23(3): 97–103.

• N. Tasdelen Fisgin, E. Tanyel, H. Sarıkaya, N. Tulek. “Evaluation of HIV/AIDS Cases.” Klimik Dergisi, 2009; 22: 18–20.

• N. Tasdelen Fisgin, E. Tanyel, K. Topgül, H. Sarıkaya, L. Doğancı, N. Tulek. “Surgical Site Infections and Risk Factors in Patients Undergoing Colon Surgery.” İnfeksiyon Dergisi, 2008; 22: 141–145.

• N. Tasdelen Fisgin, E. Tanyel, A. Ulus, N. Tulek. “Importance of Patient-Based Active Surveillance in a Neurosurgery Clinic.” İnfeksiyon Dergisi, 2008; 22: 135–140.

• E. Tanyel, N. Tasdelen Fisgin, H. Sarıkaya Genç, N. Tulek. “Evaluation of Patients with Escherichia coli Bacteremia.” Klimik Dergisi, 2008; 21: 109–111.

• B. Sönmez, H. Öztürk, Ü. Beden, N. Tasdelen Fisgin, D. Erkan. “Clinical Features and Outbreak Control in Adenoviral Keratoconjunctivitis Epidemics.” Mn Oftalmoloji, 2007; 14: 197–200.

• N. Tasdelen Fisgin, E. Tanyel, M. Zıvalıoğlu, N. Tulek. “Central Nervous System Infections: Experience from a Tertiary University Hospital.” İnfeksiyon Dergisi, 2007; 21: 169–174.

• N. Tasdelen Fisgin, S. Genç, E. Tanyel, H. Yılmaz, A. Baydın, N. Tulek. “Investigation of Infection Diseases Among Patients Presenting to the Emergency Department.” Klimik Dergisi, 2006; 19: 110–113.

• E. Tanyel, N. Tasdelen Fisgin, N. Tulek, H. Leblebicioğlu. “Evaluation of Urinary Tract Infections in Elderly Patients.” İnfeksiyon Dergisi, 2006; 20: 87–91.

• N. Tasdelen Fisgin, F. Aydın, E. Tanyel, N. Çandır, M. Sünbül, A. Bektaş, N. Tulek, H. Leblebicioğlu. “Pyoderma Gangrenosum.” Klimik Dergisi, 2006; 19: 82–84.

• N. Tasdelen Fisgin, I. Acuner, Ay. Çoban, Ş. Esen, F. Öztürk. “Acute Meningitis Caused by Alcaligenes xylosoxidans.” İnfeksiyon Dergisi, 2006; 20: 127–129.

• N. Tasdelen Fisgin, Ö. Darka, T. Fisgin, S. Hepsert, Ay. Çoban, M. Elli. “Vancomycin-Resistant Enterococcus Surveillance in Pediatric Hematology and Oncology Patients.” Mikrobiyol Bül, 2006; 40: 245–250.

• A. Akgüneş, Ay. Çoban, N. Tasdelen Fisgin, I. Acuner, B. Durupınar. “Evaluation of Phenol Ammonium Sulfate Sedimentation Method for Pulmonary Tuberculosis Diagnosis.” Tuberk Toraks, 2005; 53: 265–267.

• Ay. Çoban, Ö. Darka, N. Tasdelen Fisgin, E. Tanyel, K. Bilgin, Ç. Çekiç Cihan, A. Akgüneş, A. Birinci, B. Durupınar. “Primary Drug Susceptibility of Mycobacterium tuberculosis Strains on Blood Agar.” İnfeksiyon Dergisi, 2005; 19: 211–214.

• N. Tasdelen Fisgin, Ö. Darka, M. Sünbül, Ay. Çoban, H. Sarıkaya, B. Altun, B. Durupinar, H. Leblebicioğlu. “Case Report: Hospital Infection due to Vancomycin-Resistant Enterococcus.” Mikrobiyol Bül, 2005; 39: 351–355.

• N. Tasdelen Fisgin, I. Acuner, Ay. Çoban, T. Fisgin, A. Birinci, B. Durupinar. “Meningitis Caused by Pseudomonas Stutzeri.” Mikrobiyoloji Bülteni, 2004; 38: 261–264.

• N. Tasdelen Fisgin. “Septic Arthritis.” Hipokrat Lokomotor, 2004; 5: 122–127.

• Ş. Eren, N. Tasdelen Fisgin, N. Baykam, A. Kocagül Çelikbaş, T. Güven, B. Dokuzoğuz. “Causes of Death in HIV/AIDS Cases.” HIV/AIDS Dergisi, 2003; 6.

• N. Tasdelen Fisgin, Ş. Eren, A. Kocagül Çelikbaş, N. Baykam, B. Dokuzoğuz. “HIV/AIDS Case with Cerebral Toxoplasmosis.” HIV/AIDS Dergisi, 2003; 6: 51–54.

• N. Tasdelen Fisgin, N. Baykam, O. Portakal Akçin, B. Dokuzoğuz. “Role of Procalcitonin in Diagnosis of Sepsis and SIRS in ICU Patients.” Yoğun Bakım Dergisi, 2003; 3: 43–47.

• A. Kocagül Çelikbaş, N. Tasdelen Fisgin, N. Baykam, R. Gözüküçük, Ş. Eren, B. Dokuzoğuz. “Hepatitis A Infection in Adults.” Viral Hepatit Dergisi, 2002; 8: 455–458.

• N. Tasdelen Fisgin, N. Baykam, A. Kocagül Çelikbaş, Ş. Eren, B. Dokuzoğuz. “Factors Affecting Treatment Continuity in HIV/AIDS Cases.” HIV/AIDS Dergisi, 2002; 5: 105–107.

• N. Baykam, N. Tasdelen Fisgin, T. Fisgin, A. Kocagül Çelikbaş, Ş. Eren, B. Dokuzoğuz. “Anticardiolipin Antibody and Protein S Levels in HIV/AIDS Cases.” HIV/AIDS Dergisi, 2002; 5: 159–161.

• N. Baykam, N. Tasdelen Fisgin, A. Erbay, B. Dokuzoğuz. “Acute Hepatitis A and Plasmodium vivax Malaria.” İnfeksiyon Dergisi, 2001; 16: 367–369.

• N. Tasdelen Fisgin, Z. Şıklar, Ü. Tıran, Ö. Erdeve, R. Ünsal, Y. Dallar. “Malaria and Brucellosis Coinfection.” Sted Dergisi, 2001; 10: 452–453.

National Scientific Meeting Presentations and Conference Abstracts

• N. Tasdelen Fisgin, E. Tanyel, B. Çiçek, N. Çandır, N. Tulek. “Evaluation of Patients Developing Candidemia.” 14th Turkish Clinical Microbiology and Infectious Diseases Congress, Antalya, 2009; 290.

• E. Tanyel, A. Yılmaz Çoban, Y. Tanrıverdi Çaycı, N. Tasdelen Fisgin, N. Tulek, B. Durupınar. “In Vitro Effect of Rifampicin and Tetracycline on Brucella melitensis in Human Monocyte-Derived Macrophages.” 14th Turkish Clinical Microbiology and Infectious Diseases Congress, Antalya, 2009; 267.

• A. Deveci, Ö. Acicbe, N. Tasdelen Fisgin, E. Tanyel, N. Tulek. “Ceftriaxone-Unresponsive Neurosyphilis Case.” 14th Turkish Clinical Microbiology and Infectious Diseases Congress, Antalya, 2009; 235.

• A. Deveci, Ö. Acicbe, N. Tasdelen Fisgin, E. Tanyel, Y. Bayrı, N. Tulek. “Cost of Post-Neurosurgical Nosocomial Infections.” 14th Turkish Clinical Microbiology and Infectious Diseases Congress, Antalya, 2009; 232.

• N. Tasdelen Fisgin, Y. Tanrıverdi Çaycı, Ay. Çoban, D. Özatlı, E. Tanyel, B. Durupınar, N. Tulek. “Antimicrobial Activity of Ankaferd Blood Stopper.” 34th National Hematology Congress, Çeşme-İzmir, 2008; 106.

• E. Tanyel, N. Tasdelen Fisgin, M. Dülger, L. Doğancı, N. Tulek. “Infections in Diabetic Patients.” 1st National Diabetic Foot Infections Symposium, Selçuk-İzmir, 2008; 37.

• N. Tasdelen Fisgin, E. Tanyel, H. Sarıkaya Genç, B. Çiçek, L. Doğancı, N. Tulek. “Crimean-Congo Hemorrhagic Fever: University Hospital Experience in an Endemic Region.” 33rd Turkish Microbiology Congress, Bodrum, 2008; 808.

• E. Tanyel, Ay. Çoban, N. Tasdelen Fisgin, N. Tulek. “Investigation of Tigecycline and Ertapenem Susceptibility of Brucella melitensis Isolates on Different Media by E-Test Method.” 33rd Turkish Microbiology Congress, Bodrum, 2008; 886.

• N. Tasdelen Fisgin, E. Tanyel, H. Sarıkaya Genç, N. Tulek. “Evaluation of HIV/AIDS Cases.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 328.

• N. Tasdelen Fisgin, E. Tanyel, M. Zıvalıoğlu, N. Tulek. “Evaluation of Central Nervous System Infections.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 315.

• E. Tanyel, N. Tasdelen Fisgin, H. Sarıkaya Genç, N. Tulek. “Escherichia coli Bacteremias: Risk Factors, Etiology, and Prognosis.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 312.

• N. Tasdelen Fisgin, Y. Aliyazıcıoğlu, E. Tanyel, Ay. Çoban, F. Ülger, M. Zıvalıoğlu, Ş. Esen, H. Leblebicioğlu. “Correlation of Neopterin Levels with Mortality in Septic Patients.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 314.

• E. Tanyel, N. Tasdelen Fisgin, L. Yıldız, H. Leblebicioğlu, L. Doğancı, N. Tulek. “A Brucellosis Case Presenting Initially with Panniculitis.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 307.

• E. Tanyel, N. Tasdelen Fisgin, Ş. Esen, Ö. Darka, M. Bahçıvan, H. Leblebicioğlu, N. Tulek. “Rare Case: Endocarditis Due to Moraxella catarrhalis.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 312.

• L. Doğancı, T. Kaya, E. Tanyel, N. Tasdelen Fisgin, H. Gündoğdu, G. Kaygusuz, I. Kuzu. “Fever of Unknown Origin with Pancytopenia and Giant Liver Cysts: A T-Cell Lymphoma Case.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 375.

• E. Tanyel, N. Tasdelen Fisgin, M.S. Nural, N. Çandır, L. İncesu, N. Tulek. “Vertebral Infections: Risk Factors and General Characteristics.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 324.

• L. Doğancı, N. Tasdelen Fisgin, H. Başıbüyük, N. Tulek. “Fatal Geriatric Tetanus Case with Pulmonary Embolism Undergoing Laparotomy.” 13th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2007; 282.

• N. Tasdelen Fisgin, T. Fisgin, E. Tanyel, D. Albayrak, L. Doğancı, N. Tulek, F. Duru. “Hemophagocytic Lymphohistiocytosis Secondary to Crimean-Congo Hemorrhagic Fever.” 3rd Tropical Diseases Congress, Diyarbakır, 2006; 56.

• B. Karakuzu, B. Ümit, N. Tasdelen Fisgin, N. Arıtürk, İ. Güngör. “Case of Periorbital Necrotizing Cellulitis.” 40th National Ophthalmology Congress, Antalya, 2006; 304.

• N. Tasdelen Fisgin, S. Genç, E. Tanyel, H. Yılmaz, A. Baydın, N. Tulek. “Investigation of Infectious Diseases Among Patients Presenting to the Emergency Department.” 12th Turkish Clinical Microbiology and Infectious Diseases Congress, Belek-Antalya, 2005; 314.

• T. Fisgin, N. Belet, N. Tasdelen Fisgin, A.G. Kalaycı, D. Albayrak. “Secondary Hemophagocytic Lymphohistiocytosis in Crimean-Congo Hemorrhagic Fever.” 31st National Hematology Congress, Antalya, 2004; 172.

• A. Birinci, Ay. Kalaycı, Ş. Şener, M. Ünlü, N. Tasdelen Fisgin, B. Durupınar. “Frequency of Anti-Endomysium and Anti-Gliadin Antibodies in Patients with Suspected Celiac Disease.” 31st Turkish Microbiology Congress, Kuşadası-Aydın, 2004; 312.

• A. Akgüneş, Ay. Çoban, N. Tasdelen Fisgin, I. Acuner, B. Durupınar. “Evaluation of Phenol Ammonium Sulfate Sedimentation Method for Pulmonary Tuberculosis Diagnosis.” 31st Turkish Microbiology Congress, Kuşadası-Aydın, 2004; 370.

• Ay. Çoban, K. Bilgin, M. Uzun, N. Tasdelen Fisgin, A. Akgüneş, Ç. Çekiç Cihan, A. Birinci, B. Durupınar. “Investigation of Isoniazid and Rifampicin Susceptibility of Mycobacterium tuberculosis on Blood Agar Using Proportion Method.” 31st Turkish Microbiology Congress, Kuşadası-Aydın, 2004; 370.

• I. Acuner, G. Bayramoğlu, N. Tasdelen Fisgin, S. Hepsert, B. Durupınar. “Investigation of Antibiotic Susceptibility Patterns in Meropenem-Resistant Pseudomonas aeruginosa Strains.” 31st Turkish Microbiology Congress, Kuşadası-Aydın, 2004; 276.

• Ay. Çoban, A. Akgüneş, M. Uzun, N. Tasdelen Fisgin, K. Bilgin, Ç. Çekiç Cihan, B. Durupınar. “Resazurin Microplate Method for Isoniazid and Rifampicin Susceptibility of Mycobacterium tuberculosis Isolates.” 31st Turkish Microbiology Congress, Kuşadası-Aydın, 2004; 250.

• T. Fisgin, N. Tasdelen Fisgin, O. Özkaya, A. Dağdemir, D. Albayrak. “Cerebral Salt-Wasting Syndrome and Varicella Infection in Acute Lymphoblastic Leukemia.” 30th National Hematology Congress, İstanbul, 2003; 91.

• T. Fisgin, O. Güngör, N. Tasdelen Fisgin, F. Aydın, A. Demir, D. Albayrak. “Severe Genital Ecthyma Gangrenosum due to Pseudomonas aeruginosa in Acute Lymphoblastic Leukemia.” 30th National Hematology Congress, İstanbul, 2003; 92.

• N. Tasdelen Fisgin, N. Baykam, H. Esener, A. Erbay, B. Dokuzoğuz. “Epidemiological and Clinical Characteristics of Brucella spp. Isolated Cases.” 10th Turkish Clinical Microbiology and Infectious Diseases Congress, Adana, 2001; 357.

• Z. Şıklar, N. Tasdelen Fisgin, Ö. Erdeve, R. Ünsal, H. Altın, Y. Dallar. “Hypertriglyceridemia Associated with Kala-Azar Infection.” 2nd National Pediatric Infections Congress, Adana, 2001; 158.

• N. Tasdelen Fisgin, Z. Şıklar, Ü. Tıran, Ö. Erdeve, R. Ünsal, Y. Dallar. “Malaria and Brucellosis Coinfection.” 2nd National Pediatric Infections Congress, Adana, 2001; 157.

• N. Tasdelen Fisgin, N. Baykam, A. Kocagül Çelikbaş, Ş. Eren, B. Dokuzoğuz. “Factors Affecting Treatment Continuity in HIV/AIDS Cases.” 5th Turkey AIDS Congress, İstanbul, 2001; 109.

• N. Baykam, N. Tasdelen Fisgin, T. Fisgin, A. Kocagül Çelikbaş, Ş. Eren, B. Dokuzoğuz. “Anticardiolipin Antibody and Protein S Levels in HIV/AIDS Cases.” 5th Turkey AIDS Congress, İstanbul, 2001; 114.

• N. Tasdelen Fisgin, A. Kocagül Çelikbaş, N. Baykam, R. Gözüküçük, A. Erbay, A. Çolpan, B. Dokuzoğuz. “Adult Hepatitis A Cases.” 5th National Viral Hepatitis Symposium, Ankara, 2000.

• Ö. Ergönül, N. Baykam, A. Erbay, N. Tasdelen Fisgin, Z. Demiroğlu, B. Dokuzoğuz. “Assessment of Knowledge, Attitude and Behavior of Healthcare Workers Regarding Infection Risks.” 1st National Congress on Healthcare Worker Health, Ankara, 1999; 177.